Collecting Data on People’s Results with TSO

Since my presentation on my experience with TSO and my son last October at Mount Sinai, a number of people have connected with doctors and tried TSO for the treatment of certain symptoms of autism. Many of these people (but not all) have registered with this site and have informally shared

continue reading >>

AutismTSO site back up

After a few weeks of down-time the site is now back up and functioning. Some userid’s had been inadvertently deactivated by me during maintenance. These id’s have now been reactivated. Sorry about any inconvenience. 

continue reading >>

FDA Approves IND Application

Yesterday the IND (Investigational New Drug) application for the Multiple Sclerosis study with TSO at the University of Wisconsin was approved by the US FDA. “Helminth-induced immunomodulation therapy (HINT) in relapsing-remitting multiple sclerosis (RRMS)”, sponsored by the National

continue reading >>

Dose Response

After almost two years, in an act of either bravery or insanity (depending on how you look at it), I decided to see if Lawrence could be maintained on a lower dose of TSO. I reduced his last two doses by one third, to approximately 1600 ova. This is done by shaking the bottle and just

continue reading >>

Misconceptions about my hypothesis

Based on questions and comments I’ve gotten I’d like to clarify certain misconceptions about my hypothesis:

What my hypothesis is: First, you have to accept the Hygiene Hypothesis as fact, i.e. the absence of helminths in the human gut causes autoimmune response and allergies in

continue reading >>